SYSTEMATIC REVIEW article
Front. Endocrinol.
Sec. Diabetes: Molecular Mechanisms
Genetic Landscape of Neonatal Diabetes Mellitus (NDM) in the Middle East, North Africa, and Türkiye (MENAT): A Systematic Review
Provisionally accepted
Salma Younes1,2
Faisal Elmi Ibrahim3
Ofelia Masoud2
Sara Awwad2Halah Noor Nasir2
Hatem Zayed2*
Nader Al-Dewik3*- 1Qatar University, Doha, Qatar
- 2Department of Biomedical Sciences, College of Health Sciences, Qatar University, Doha, Qatar
- 3Women’s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Neonatal Diabetes Mellitus (NDM) is a rare, heterogeneous condition characterized by insulin-requiring hyperglycemia within the first six months of life. Although many NDM-associated genetic variants have been identified globally, the mutational spectrum and its relationship to phenotypic diversity within the Middle East, North Africa and Türkiye (MENAT) remain underexplored. Objective: To systematically review genetically confirmed variants reported in MENAT NDM and summarize genetic diversity and genotype-phenotype correlations. Methods: We performed a PRISMA-compliant search of PubMed, Scopus, Science Direct, Web of Science, and Google Scholar through July 2024. Studies of MENAT patients with pathogenic or likely pathogenic genetic variants in NDM were included. Data on genetic variants, clinical phenotypes, and treatment outcomes were extracted and synthesized. Results: Across 95 studies, we identified 195 variants in 23 genes, including 107 variants currently reported only in MENAT populations. EIF2AK3 accounted for largest proportion (22%), followed by KCNJ11 (11%) and ABCC8 (10%). Genotype-phenotype showed a broad spectrum of presentations, from isolated NDM to multisystem syndromes. Conclusion: MENAT NDM exhibits substantial genetic heterogeneity with clear diagnostic and therapeutic implications. Early genetic testing enables precision care, including potential sulfonylurea therapy in patients with K-ATP channel variants (KCNJ11/ABCC8), though treatment outcome reporting remains heterogeneous. Further studies are needed to interrogate the function of novel variants and elucidate disease mechanisms.
Keywords: neonatal diabetes, NDM, MENAT region, genetic diversity, genotype-phenotypecorrelation
Received: 09 Oct 2024; Accepted: 10 Nov 2025.
Copyright: © 2025 Younes, Ibrahim, Masoud, Awwad, Nasir, Zayed and Al-Dewik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hatem Zayed, hatem.zayed@qu.edu.qa
Nader Al-Dewik, naldewik@hamad.qa
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.